LoginRegister
Scholarships

BOLS-FFUP-26-13

Researcher scholarship
Faculty of Pharmacy of the University of Porto
positions
1
Published Date
28/05/2026
Open to applications
28/05/2026 to 15/06/2026

Information

Procedure code
BOLS-FFUP-26-13
Category
Researcher scholarship
Area
Ciências Farmacêuticas, Análises Clínicas, Toxicologia ou áreas afins-CD-CORE NORTE2030-FEDER-01786100 / Ciências Farmacêuticas, Análises Clínicas, Toxicologia ou áreas afins-CD-CORE NORTE2030-FEDER-01786100
Constitutive entities
Faculty of Pharmacy of the University of Porto

Evaluation

Curriculum

8 pts
a) Ranking of the candidate's highest grade
8 pts
Experience in cell culture and in the laboratory research activities referred to in the Preferred Conditions, documented by (co-)authorship in scientific communications/publications
4 pts
c) Previous publications and relevance to the topic

Interview

5 pts
Communication skills (in Portuguese and English)
5 pts
Problem-solving and critical analysis skills
5 pts
Motivation and initiative within the scope of the project topic
5 pts
Research experience and previous teamwork

Jury

MM
Maria Alice dos Santos Silva Gomes Martins
Full Professor
Faculty of Pharmacy of the University of Porto
MV
Maria João Portugal Couto Valente
Assistant Professor
Faculty of Pharmacy of the University of Porto
RC
Rosa Cristina Barreto Catarino
Assistant Professor
Faculty of Pharmacy of the University of Porto
GS
Georgina Correia da Silva
Substitute
Associate Professor
Faculty of Pharmacy of the University of Porto
LB
Luís Filipe Barbosa Amado Belo
Substitute
Professor Auxiliar com agregação
Faculty of Pharmacy of the University of Porto

Publications

Notice
The Faculty of Pharmacy of the University of Porto hereby opens this call for applications for 1 (one) research studentship, for a student enrolled in a doctoral programme or master's enrolled in a non-degree course, to carry out R&D activities within the scope of the project “CD-CORE: Diagnóstico do Cancro, Terapêuticas e Estilo de Vida: Estratégias Para Ultrapassar A Resistência À Quimioterapia E Os Efeitos Adversos A Longo Prazo”.
(PT) Aviso_BI_PT Norte 2030.pdf
(EN) Aviso_BI_ING, Norte 2030.pdf